Phenotypic heterogeneity influences apoptotic susceptibility to retinoic acid and cis-platinum of rat arterial smooth muscle cells in vitro implications for the evolution of experimental intimal thickening

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 21, Issue 7, 2001, Pages 1118-1123

  Orlandi, Augusto ^a   Francesconi, Arianna ^a   Cocchia, Domenico ^a   Corsini, Alberto ^b   Spagnoli, Luigi Giusto ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

All trans retinoic acid; Atheromatosis; Cis platinum; Flow cytometry; Restenosis

Indexed keywords

CASPASE 3; CELLULAR RETINOL BINDING PROTEIN; CISPLATIN; IMMUNOGLOBULIN G ANTIBODY; PROTEIN BAX; PROTEIN BCL 2; RETINOIC ACID; THYMIDINE;

ANIMAL CELL; APOPTOSIS; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROMATOSIS; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; ENDOTHELIUM INJURY; EPITHELIOID CELL; FLOW CYTOMETRY; MALE; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SMOOTH MUSCLE FIBER; VASCULAR LESION;

EID: 0035720168     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/hq0701.092144     Document Type: Article

References (46)

1. The pathogenesis of atherosclerosis: A perspective for the 1990s
2. Mechanisms of stenosis after arterial injury
3. Cytoskeleton of rat aortic smooth muscle cells: Normal conditions and experimental intimal thickening
4. Intimal injury in vivo activates vascular smooth muscle cell migration and explant outgrowth in vitro
5. Significance of quiescent smooth muscle migration in the injured rat carotid artery
6. Rat aortic smooth muscle cells isolated from different layers and at different times after endothelial denudation show distinct biological features in vitro
7. Cellular retinol-binding protein-1 is expressed by distinct subsets of rat arterial smooth muscle cells in vitro and in vivo
8. Phenotypic heterogeneity of rat arterial smooth muscle cell clones: Implications for the development of experimental intimal thickening
9. The intima: Development and monoclonal responses to injury
10. Apoptosis participates in cellularity regulation during rat aortic intimal thickening
11. Evidence for apoptosis in human atherogenesis and in a rat vascular injury model
12. Phenotypic features of smooth muscle cells during the evolution of experimental carotid artery intimal thickening
13. A monoclonal antibody against α-smooth muscle actin: A new probe for smooth muscle differentiation
14. Determinants of vascular smooth muscle cell apoptosis after balloon angioplasty injury
15. Aging influences development and progression of early aortic atherosclerotic lesions in cholesterol-fed rabbits
16. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
17. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications
18. Apoptotic DNA fragmentation is detected by semiquantitative ligation-mediated PCR of blunt DNA ends
19. Retinoic acid regulates arterial smooth muscle cell proliferation and phenotypic features in vivo and in vitro through an RARα-dependent signaling pathway
20. Apoptosis in human atherosclerosis and restenosis
21. Replication of smooth muscle cells in vascular disease
22. Regulation of differentiated properties and proliferation of arterial smooth muscle cells
23. Human vascular smooth muscle in culture
24. Kinetics of cellular proliferation after arterial injury, I: Smooth muscle growth in the absence of endothelium
25. Actin expression in smooth muscle cells of rat aortic intimal thickening, human atheromatous plaque, and cultured rat aortic media
26. Cultivated human arterial smooth muscle displays heterogeneous pattern of growth and phenotypic variation
27. Growth characteristics and cytoskeletal organization of cultured smooth muscle cells from human primary stenosing and restenosing lesions
28. Proliferative activity and α-smooth muscle actin expression in cultured rat aortic smooth muscle cells are differently modulated by transforming growth factor-α and heparin
29. Cellular heterogeneity of the vascular tunica media: Implications for vessel wall repair
30. 2-induced cytotoxicity in "epithelioid" smooth muscle cells: Implications for neointima regression
31. Retinoids and arterial smooth muscle cells
32. A retinoic acid response element from the rat CRBPI promoter is activated by an RAR/RXR heterodimer
33. Cellular retinal-binding protein-1 is transiently expressed in granulation tissue fibroblasts and differentially expressed in fibroblasts cultured from different organs
34. Cell death in human atherosclerotic plaque involves both oncosis and apoptosis
35. Activation of a programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hypothermia
36. Cisplatin induces a persistent activation of JNK that is related to cell death
37. Apoptosis of human vascular smooth muscle cells derived from normal vessel and coronary atherosclerotic plaque
38. Bcl-2 heterodimerizes in vivo with a conserved homolog, bax, that accelerates programmed cell death
39. Apoptosis and overexpression of bax protein and bax mRNA in smooth muscle cells within intimal hyperplasia of human radial arteries
40. Sensitivity to Fas-mediated apoptosis is determined below receptor level in human vascular smooth muscle cells
41. Endothelin-1 attenuates ω3 fatty acid-induced apoptosis by inhibition of caspase 3
42. Essential contribution of caspase 3 CPP32 to apoptosis and its associated nuclear changes
43. The nuclear factor-κB signaling pathway participates in dysregulation of vascular smooth muscle cells in vitro and in human atherosclerosis
44. Suppression of TNF-α-induced apoptosis by NF-κB
45. Nuclear factor-κB regulates induction of apoptosis and inhibitor of apoptosis protein-1 expression in vascular smooth muscle cells
46. Smooth muscle apoptosis during vascular regression in spontaneously hypertensive rats